Default company panoramic image

Smart Perfusion

Smart Perfusion's mission is to reduce the wait list for kidney and liver transplants by increasing the yield from a large donor pool.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location United States
  • Currency USD
  • Employees 0
  • Website

Company Summary

VasoWave is the embodiment of patented and patent pending technology that rinses organs effectively and extends kidney perfusion from less than 24 hours to 72 hour and liver perfusion from less than 12 hours to 24 hours. Transplant surgeons will have access to quantifiable organ assessment data prior to implant. Customers are transplant professionals in Organ Procurement Organizations and Transplant Centers.


  • Default avatar
    George Barr

    Mr. Barr is a founder and President. He has over thirty years of successful technology commercialization experience. Mr. Barr has a BA from Washington and Lee University and an MBA from Virginia Tech.

  • Default avatar
    Don Faulkner

    CTO Don Faulkner is an engineer who specializes in fluid dynamics, and who has over thirty years of technology commercialization experience.

  • Default avatar
    John L. Robertson, PhD, VMD

    CSO John L. Robertson, VMD and PhD (Nephrology) has extensive experience in academia, industry and FDA.

  • Default avatar
    David Gerber, MD

    CMO David A. Gerber, MD is Chief of Transplantation, University of North Carolina at Chapel Hill.


  • Default avatar
    Default avatar
    McCannon Rogers Driscoll & Associates L L P